A natural inhibitor of c-Met that sensitizes head and neck cancer cells resistant to EGFR and PI3K co-targeting

被引：0
|
作者：
Anisuzzaman, Asm [1 ]
Hague, Abedul [2 ]
Butler, Brian [3 ]
Amin, Arm R. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Marshall Univ, Huntington, WV USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-706
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
706
引用
收藏
页数：2
相关论文
共 50 条
  • [41] MicroRNA mir-93 activates oncogenic c-Met/PI3K/Akt pathway targeting PTEN in hepatocellular carcinoma
    Ohta, Katsuya
    Hoshino, Hiromitsu
    Hata, Keisuke
    Wang, Jinhua
    Huang, Sharon
    Menon, Vijay
    Colquhoun, Steven
    Hoon, Dave S. B.
    CANCER RESEARCH, 2014, 74 (19)
  • [42] Targeting immunosuppressive myeloid cells in oral cavity cancer with the PI3Kδ/γ isoform inhibitor duvelisib
    Davis, Ruth
    Moore, Ellen
    Clavijo, Paul E.
    Silvin, Chris
    Van Waes, Carter
    Chen, Zhong
    Allen, Clint
    CANCER RESEARCH, 2016, 76
  • [43] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
    Simpson, Daniel R.
    Mell, Loren K.
    Cohen, Ezra E. W.
    ORAL ONCOLOGY, 2015, 51 (04) : 291 - 298
  • [44] Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
    Chen, Oleg
    Manig, Friederike
    Lehmann, Loreen
    Sorour, Nagwa
    Lock, Steffen
    Yu, Zhanru
    Dubrovska, Anna
    Baumann, Michael
    Kessler, Benedikt M.
    Stasyk, Oleh
    Kunz-Schughart, Leoni A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2021, 78 (06) : 3021 - 3044
  • [45] INVESTIGATING MECHANISMS OF PI3K INHIBITOR RESISTANCE IN HEAD AND NECK SQUAMOUS CELL CARCINOMA
    Vien, M.
    Young, C. D.
    Wang, X.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (01) : 110 - 110
  • [46] Combination of PI3K targeting with cetuximab and irradiation: a preclinical study on an orthotopic xenograft model of head and neck cancer
    Milano, Gerard
    Bozec, Alexandre
    Ebran, Nathalie
    CANCER RESEARCH, 2016, 76
  • [47] Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis
    Huang, Xiaojun
    Wang, Chaoqun
    Sun, Jinmin
    Luo, Jun
    You, Jiangzhou
    Liao, Linchuan
    Li, Mingyuan
    ONCOLOGY LETTERS, 2018, 15 (01) : 947 - 955
  • [48] Activated c-Met signals through PI3K with dramatic effects on cytoskeletal functions in small cell lung cancer
    Maulik, G
    Madhiwala, P
    Brooks, S
    Ma, PC
    Kijima, T
    Tibaldi, EV
    Schaefer, E
    Parmar, K
    Salgia, R
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2002, 6 (04) : 539 - 553
  • [49] The c-MET/PI3K/BCRP Signaling Is Involved in Ovarian Cancer Cell Resistance to Photodynamic Therapy and Doxorubicin Treatment
    Jung, Kyeong-Ah
    Choi, Bo-Hyun
    Kwak, Mi-Kyoung
    FREE RADICAL BIOLOGY AND MEDICINE, 2014, 76 : S127 - S127
  • [50] Harvey ras (HRAS) mutations in head and neck cancer (HNC) and dependence on PI3K signaling and resistance to EGFR inhibition
    Endhardt, Katharina
    Khattri, Arun
    Keck, Michaela K.
    Zuo, Zhixiang
    Rieke, Damian
    Ress, Anna Lena
    Braegelmann, Johannes
    Leung, Kelley
    Mahmutoglu, Derya
    Vokes, Everett E.
    Seiwert, Tanguy Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345